Alleima AB (publ) (ALLEI) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hi everyone and welcome to the presentation of the second quarter 2025 interim report for ALERMA. My name is Emelie Alm and I am head of Investor Relations. I'm joined by Göran Görkman, president and CEO, and Olof Bengtsson, CFO. So as usual, Göran and Olof will take you through the results and then we will have a Q&A session. You can ask questions either in the chat, in the webcast or on the conference call. And as always, safety is our top priority, and we trust that you know the safety routines of where you are located. So with that, I would like to hand over to you, Jaron. Thank you, Emily. Hi, everyone, and thank you for listening. So I'll start with the highlights of the quarter. Well, I think we're performing okay in a challenging market environment with the mixed demand. Our broad exposure reduces volatility, but of course we note a negative organic top-line growth. Our order intake rolling 12 declined 2%, and revenues in the quarter minus 4% from high comps last year. A backlog is still good in important segments such as oil and gas, in nuclear and in medical, a good product mix and visibility for the near-term future. In the more volume business like industrial segment and in chem, petro, in Europe in particular, the backlog is weaker. Our adjusted EBIT margin declined to near 9.5%, which I think considering the lower revenues and a significant FX headwind shows resilience and a good leverage. And I take this as a proof that we are doing a lot of things right with our strategy. We have a good product mix. Excluding FX, the margin would have been 11.4%. But at the same time, there is room for improvement. So I think parts of the business is performing well, while others clearly have some challenges. We did not have any significant direct effects from tariffs...